We have estimated LRP3 expression in the frontal cortex of middle-aged (MA) individuals and in cases with Alzheimer’s disease (AD)-related pathology, and after overexpression in CHO cells. This evidence concerns the gene LRP3 and early-onset autosomal dominant Alzheimer disease.